Skip to content

A Study on the Effects on Glucose Regulation, Inflammation and Serum Lipids After Fish Protein Supplementation in Elderly (GRIPE)

A 6-week Pilot Study to Investigate the Effects of Protein Hydrolysate From Blue Whiting on Glucose Regulation, Inflammation and Serum Lipids in Elderly Nursing Home Residents From Western Norway

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03529344
Acronym
GRIPE
Enrollment
24
Registered
2018-05-18
Start date
2016-08-31
Completion date
2021-12-31
Last updated
2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Blood Sugar; High, Inflammation, Muscle Loss, Muscle Weakness

Brief summary

The elderly population have and increased risk of loss of both muscle mass and function and is therefore recommended a higher protein intake than the healthy adult population. These age-related changes in muscle function may be explained by chronic low-grade inflammation and insulin resistance. Despite the recommendation of a higher protein intake, little is known about how different protein sources may affect the metabolic health in this population. Analysis of amino acid composition show that fish can be a good protein source for humans. Many fish species are today used as feed ingredients, rather than a protein source for humans. A few studies conducted in humans and rats show that proteins from fish may improve glucose tolerance, reduce inflammation and improve lipid metabolism, indicating that proteins from fish may not only serve as a valuable nutrient but could also hold specific health promoting properties. The present study will investigate the effects of a protein hydrolysate from blue whiting, a fish species normally used to produce fish meal for aquaculture industry, on glucose homeostasis, inflammation and serum lipids in elderly nursing home residents.

Detailed description

Participants receive 6g per day of protein hydrolysate from blue whiting as protein powder mixed with a non-caloric juice for 6 weeks.

Interventions

Dietary Supplement: Blue whiting protein hydrolysate 6g protein per day for 6wk

DIETARY_SUPPLEMENTPlacebo Comparator: Control

Control group will receive non-caloric juice without protein supplementation

Sponsors

University of Bergen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* \>60 years * both genders * nursing home resident

Exclusion criteria

* life expectancy \< 6 months * severe cognitive impairment * allergies towards fish, milk, egg * weight loss \>5% last 3 months

Design outcomes

Primary

MeasureTime frameDescription
Participant compliance6 weeksInvestigate the participant compliance based daily registrations by nursing home staff
Participant dropout rate6 weeksNumber of participants that completed the intervention period

Secondary

MeasureTime frameDescription
C-reactive protein in serum6 weeksC-reactive protein (a marker of inflammation) will be analysed in fasting serum
Glucose regulation6 weeksGlucose concentration will be measured in fasting serum
Monocyte chemoattractant protein-1 in serum6 weeksMonocyte chemoattractant protein-1 (a marker of inflammation) will be analysed in fasting serum
Interleukin-6 in serum6 weeksInterleukin-6 (a marker of inflammation) will be analysed in fasting serum
Insulin6 weeksInsulin will be measured in fasting serum/plasma

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026